We are live on
!
Find out more
GC
Grimes & Company Portfolio holdings
AUM
$4.62B
1-Year Est. Return
29.71%
This Fund
S&P 500
This Quarter
Est. Return
+19.07%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.64%
AUM
$1.44B
AUM Growth
+$344M
(+31%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
11.87%
Top 10 Holdings %
Top 10 Hldgs %
38.33%
Holding
267
New
32
Increased
87
Reduced
92
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Preferred Securities and Income ETF
FPE
|
+$65.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$55.9M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$55.4M |
| 4 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$46.3M |
| 5 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$144M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$72.2M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$16.3M |
| 4 |
VanEck High Yield Muni ETF
HYD
|
+$12.4M |
| 5 |
RTN
Raytheon Company
RTN
|
+$7.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.17% |
| 2 | Technology | 12.57% |
| 3 | Healthcare | 7.87% |
| 4 | Industrials | 4.96% |
| 5 | Financials | 4.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
iShares Core US Aggregate Bond ETF
AGG
$137B
| $14M | 0.97% |
118,484
-616,337
| -84% | -$72.2M |
|
27
Amgen
AMGN
$203B
| $13.5M | 0.94% |
57,350
-536
| -0.9% | -$122K |
|
28
Accenture
ACN
$116B
| $13M | 0.9% |
60,561
-823
| -1% | -$156K |
|
|
NVO
29
Novo Nordisk
NVO
$184B
| $13M | 0.9% |
396,952
-8,898
| -2% | -$284K |
|
30
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
| $11.7M | 0.81% |
+199,769
| New | +$11.7M |
|
31
Qualcomm
QCOM
$197B
| $11.4M | 0.79% |
124,741
-2,333
| -2% | -$187K |
|
32
TSMC
TSM
$2.17T
| $10.7M | 0.75% |
188,938
-2,908
| -2% | -$153K |
|
33
Expedia Group
EXPE
$34.4B
| $10.5M | 0.73% |
127,523
-1,191
| -0.9% | -$86.6K |
|
34
Medtronic
MDT
$118B
| $10.3M | 0.71% |
111,903
+80
| +0.1% | +$7.67K |
|
35
State Street Technology Select Sector SPDR ETF
XLK
$120B
| $10M | 0.7% |
192,352
+33,572
| +21% | +$1.58M |
|
|
EA
36
DELISTED
Electronic Arts
EA
| $10M | 0.7% |
75,983
-1,072
| -1% | -$127K |
|
37
Packaging Corp of America
PKG
$20.6B
| $9.93M | 0.69% |
99,489
+434
| +0.4% | +$41.3K |
|
|
XLNX
38
DELISTED
Xilinx Inc
XLNX
| $9.82M | 0.68% |
99,846
-705
| -0.7% | -$62.5K |
|
39
RTX Corp
RTX
$265B
| $9.53M | 0.66% |
154,622
+135,282
| +699% | +$8.44M |
|
40
United Parcel Service
UPS
$84B
| $9.46M | 0.66% |
85,117
+355
| +0.4% | +$35.4K |
|
41
Bristol-Myers Squibb
BMY
$130B
| $9.39M | 0.65% |
159,713
-3,264
| -2% | -$195K |
|
42
Sysco
SYY
$37.7B
| $9.26M | 0.64% |
169,379
+163,564
| +2,813% | +$8.6M |
|
43
State Street Energy Select Sector SPDR ETF
XLE
$42B
| $9.24M | 0.64% |
+488,182
| New | +$9.08M |
|
44
Expeditors International
EXPD
$24.6B
| $9.22M | 0.64% |
121,291
-817
| -0.7% | -$59.7K |
|
45
T. Rowe Price
TROW
$21.8B
| $9.22M | 0.64% |
74,634
-325
| -0.4% | -$37.1K |
|
46
Johnson & Johnson
JNJ
$644B
| $9.13M | 0.63% |
64,916
+229
| +0.4% | +$33.4K |
|
47
CVS Health
CVS
$117B
| $9.09M | 0.63% |
139,973
+2,269
| +2% | +$143K |
|
48
Robert Half
RHI
$3.8B
| $9.09M | 0.63% |
172,042
+3,388
| +2% | +$161K |
|
49
Meta Platforms (Facebook)
META
$1.72T
| $9.04M | 0.63% |
39,815
+842
| +2% | +$176K |
|
50
UnitedHealth
UNH
$337B
| $8.99M | 0.62% |
30,482
-373
| -1% | -$107K |
|
Similar funds
CW
F
TYCC
AT
CCA
AF
FLSM
BT
Grimes & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Grimes & Company held 267 positions worth $1.44B, up 31% from $1.1B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Grimes & Company deployed $171M of net new capital in Q2 2020, opening 32 new positions and adding to 87 existing holdings. Its largest new stake was First Trust Preferred Securities and Income ETF: 3,607,715 shares worth $66.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $144M trimmed.
- Grimes & Company's largest Q2 2020 buy was First Trust Preferred Securities and Income ETF: 3,607,715 shares worth $66.5M.
- Grimes & Company added most to iShares Core S&P Small-Cap ETF in Q2 2020, an estimated $55.9M increase.
- Grimes & Company's biggest Q2 2020 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $144M.
- Grimes & Company fully exited VanEck High Yield Muni ETF in Q2 2020, selling an estimated $12.4M.
- Grimes & Company's ten largest holdings make up 38% of its $1.44B portfolio in Q2 2020.
- Grimes & Company opened 32 new positions and closed 18 in Q2 2020.
- Grimes & Company's portfolio value rose 31% quarter-over-quarter to $1.44B.
Based on Grimes & Company's 13F filing for Q2 2020, filed 31 Jul 2020.